-
Raphinha, Lopez strike again as Barca beat Athletic
-
Welbeck scores first Chelsea goal in League Cup win over Luton
-
Dos Santos, Russell set world records in 'crazy' Zurich Diamond League
-
Arsenal face depleted Aston Villa, Spurs seek return on £300m spend
-
Dos Santos upstages Warholm for blistering new 400m hurdles world record
-
Werro edges ever closer to elusive women's 800m world record
-
US Open women's singles: Three talking points
-
Callaway cuts ties with golf media firm over violent ad
-
American Masai Russell sets new women's 100m hurdles world record
-
Trump says Putin won't attack NATO territory
-
Smith and Cox revive England after Abbas strikes for Pakistan
-
Labor Day 2026: Complete Starter Tool Kit Under $375
-
Brazil's Alison Dos Santos sets new men's 400m hurdles world record
-
Tamil Nadu Govt Assigns Ministers to Oversee Chennai Monsoon Preparedness
-
The Nile Theater Announces Full 2026 Concert Lineup Including Menzingers and Shakey Graves
-
Alfred gets revenge on Jefferson-Wooden in Zurich 100m
-
Venezuelan Artist Oswaldo Vigas Retrospective Opens in Guangzhou
-
US Open men's singles: Three talking points
-
Smith and Cox revive England against Pakistan after Abbas strikes
-
Michael Strahan Welcomes Fifth Child with Girlfriend Kayla Quick
-
Zambia opposition leader held in treason probe: police
-
Kuminga’s Timberwolves Deal Saves Millions in Taxes Despite Lower Pay Than Lakers Offer
-
Corals show El Nino intensifying as planet warms: study
-
Trump says Russia is 'not going to attack' NATO territory
-
Russia dismisses as 'scare stories' US reports about attacking NATO
-
OpenAI Tests 'Persistent Mode' for Codex AI Agent
-
UEFA target Infantino for 'criminal mismanagement', suspend boycott threat
-
PSG to face Barcelona, Man City and Villa in Champions League as draw is made
-
Piracy attacks off Somalia surge in 2026: AFP analysis of IMO data
-
Two killed, one arrested, at school near Berlin: police
-
Tottenham land Marmoush from Manchester City
-
Cox defies Pakistan after Abbas's treble strike rocks England
-
YZi Labs Backs TermMax to Advance On-Chain Bond Market Infrastructure
-
Bosnian Serb war criminal Ratko Mladic dead
-
Nvidia boosts tech stocks but caution dominates ahead of Fed speech
-
Ogura to miss Aragon MotoGP after hand surgery
-
Pogacar holds off Mas to claim Vuelta stage six victory
-
Severe Thunderstorms Hit Eastern Australia After SA Deluge
-
A lasting Dolly Parton legacy: childhood literacy
-
More than goals: What Mourinho wants from Real Madrid's Mbappe
-
S.Africa sounds alarm as infant vaccinations plummet
-
Finland defends shores against oil spill risk
-
Toulouse have salary cap fine reduced on appeal
-
Iraola hoping for 'good news soon' in Liverpool pursuit of Barcola
-
Tech stocks lifted by Nvidia but caution dominates ahead of Fed speech
-
Iran executes over 500 people in 2026: rights group
-
'Smart cricketer' Dinusha helps Sri Lanka draw second India Test
-
Srebrenica: Massacre that outraged the world
-
Zambia opposition leader surrenders to police: state media
-
After US settlement, EU says Meta must 'protect our kids too'
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this revolutionary platform is set to transform the traditional sales process, one touchpoint at a time.
"Imagine a world where technology doesn't just assist your sales teams but replaces repetitive tasks entirely," highlighted in the podcast. "AI Maverick learns, adapts, and delivers results, letting your team focus on strategy.
Revolutionizing Sales with AI-Powered Automation
Built to solve the most common challenges of traditional sales teams, such as high SDR turnover, inefficiency, and inconsistent messaging, AI Maverick uses advanced AI and automation to replace fragmented sales processes with a unified, intelligent system.
Unmatched Sales Velocity and Scale: AI Maverick addresses inefficiencies in lead targeting and follow-ups with two-way communication, acting swiftly on buyer intent signals. Whether handling 10, 100 or 100,000 interactions, the platform scales effortlessly, ensuring 24/7 engagement without compromising efficiency or personalization.
Seamless Integration: The technology streamlines data management and reduces the sales cycle, moving prospects seamlessly from initial contact to conversion.
Buyer-Centric Focus: AI Maverick acts on buyer intent in real-time, ensuring leads are engaged at the perfect moment. "You need to enter the conversation already taking place in the customer's mind." - Robert Collier, early 20th century.
Tune in Now:
In the podcast, you'll hear insights on how AI Maverick is reshaping the sales landscape, from rapid MVP deployment to ensuring compliance at scale. Whether you're an investor, business leader, or tech enthusiast, this is a must-listen episode:
🎧 YouTube: https://youtu.be/DOQZxRYhmu0?si=KGBbSik46bBOzfCf
🎧 Spotify:https://open.spotify.com/episode/1OOHkCIiW7lnD0JckLJNqW?si=SYS5uebzQkGdU3-YxwwoWQ
Stay Connected
Stay updated on AI Maverick's journey as we gear up to launch AI Maverick 2.0, the next-generation platform that's set to redefine sales automation. Turn on press release notifications to catch every breakthrough.
For more information, please contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
[email protected]
About BizUnlearned Podcast:
BizUnlearned is the ultimate podcast for project managers, business leaders, and entrepreneurs looking to elevate their skills and foster meaningful connections. Hosted by industry experts William (Cowboy) H. Volpé III, a renowned project management authority, and Mark Layder, a visionary in business coaching and development, each episode dives deep into the latest trends, tools, and strategies driving successful projects and business growth. Join us for engaging discussions, real-world insights, and practical takeaways to thrive in today's dynamic business landscape.
https://projectvictories.com/bizunlearned-hosts/
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate", "believe", "continue", "could", "estimate", "expect", "intend", "may", "ongoing", "plan", "potential", "predict", "project", "should", "will", "would", or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on OTCmarkets.com.
SOURCE: Bionoid Pharma, Inc.
Ch.P.Lewis--AT